Page breadcrumb nav

VAERS Report 2156953

Case Report Section

Détails du rapport Vaer

Âge: 52 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (MODERNA))

Type : Coronavirus 2019 vaccine

Fabricant: MODERNA

Lot: unknown


Nom: COVID19 (COVID19 (UNKNOWN))

Type : Coronavirus 2019 vaccine

Fabricant: UNKNOWN

Lot: pv46673


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-03-24
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

muscle spasm; headache occurring; this case was received via the regulatory authority ra (reference number: gb-mhra-adr 25014906) on 27-feb-2022 and was forwarded to moderna on 27-feb-2022. this regulatory authority case was reported by a consumer and describes the occurrence of headache (headache occurring) and muscle spasms (muscle spasm) in a 52-year-old female patient who received mrna-1273 (moderna covid-19 vaccine) for an unknown indication. co-suspect product included non-company product covid-19 vaccine nrvv ad (chadox1 ncov-19) (covid-19 vaccine astrazeneca) for covid-19 vaccination. no medical history information was reported. on 24-mar-2021, the patient received dose of covid-19 vaccine nrvv ad (chadox1 ncov-19) (covid-19 vaccine astrazeneca) (unknown route) 1 dosage form. on 24-nov-2021, the patient received third dose of mrna-1273 (moderna covid-19 vaccine) (unknown route) 1 dosage form. on 24-mar-2021, after starting mrna-1273 (moderna covid-19 vaccine), the patient experienced headache (headache occurring) (seriousness criterion medically significant). on 25-mar-2021, the patient experienced muscle spasms (muscle spasm) (seriousness criterion medically significant). on 26-mar-2021, muscle spasms (muscle spasm) had resolved. at the time of the report, headache (headache occurring) had not resolved. the action taken with mrna-1273 (moderna covid-19 vaccine) (unknown) was unknown. concomitant medication use information was not provided by reporter. patient has not had symptoms associated with covid-19 and not had a covid-19 test. patient was not currently breastfeeding. patient had not tested positive for covid-19 since having the vaccine. patient was not enrolled in clinical trial. the dosage text for suspect drug was reported as dose 3b. treatment medication use information was not provided by reporter. company comment: this regulatory authority case concerns a 52-year-old female patient with medical history (not reported), who experienced the serious unexpected event of headache, and muscle spasms. the events occurred before the dose of mrna-1273, moderna covid-19 vaccine. how ever patient received dose of covid-19 vaccine nrvv ad (chadox1 ncov-19) (covid-19 vaccine astrazeneca) and events occurred on the same day. the benefit-risk relationship f mrna-1273, moderna covid-19 vaccine is not affected by this report.; sender's comments: this regulatory authority case concerns a 52-year-old female patient with medical history (not reported), who experienced the serious unexpected event of headache, and muscle spasms. the events occurred before the dose of mrna-1273, moderna covid-19 vaccine. how ever patient received dose of covid-19 vaccine nrvv ad (chadox1 ncov-19) (covid-19 vaccine astrazeneca) and events occurred on the same day. the benefit-risk relationship f mrna-1273, moderna covid-19 vaccine is not affected by this report

Données de laboratoire
na
Liste des symptômes
headache muscle spasms
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na